To include your compound in the COVID-19 Resource Center, submit it here.

Duke-Margolis proposes value-based pricing model for antimicrobials

The Duke-Margolis Center for Health Policy released a paper detailing its Priority Antimicrobial Value and Entry (PAVE) Award, which proposes value-based payment reform in U.S. antimicrobial drug policy.

Read the full 282 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE